Disease detection, access to care and remote patient monitoring are just a few areas in which AI is expected to aid rheumatology, but there will still be room for the human touch.
The Burden Imposed by Prior Authorization Requirements
‘Prior authorizations are the bane of our existence as rheumatologists,’ says Physician Editor Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS. ‘How bad is it, how can we manage them, and how is the ACR helping? Read on in this month’s Editor’s Pick.’ Healthcare providers consider prior authorization (PA) a significant burden, but to different degrees…
Rheum for Everyone, Episode 10: Demystifying AI
Hosted by Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS, physician editor, The Rheumatologist Amidst mounting excitement over emerging artificial intelligence tools, Dr. Kumar cautions against the expectation that technology will offer a quick fix to complex, systemic healthcare problems. Go to current issue.
Demystifying Artificial Intelligence in Rheumatology
As I was aimlessly browsing the web one night, I noticed a strange ad on the side. It was for a bird feeder powered by artificial intelligence (AI). I don’t know exactly what prompted the Google ad algorithm to show me this particular advertisement, but I was nevertheless struck by it. Against my better judgment,…
Ethics Forum: Regarding Chatbots in Rheumatology
Chatbots are not a new concept, but have recently gained popularity and traction. Launched in late 2022, ChatGPT (Chat Generative Pre-Trained Transformer) is a web-based platform designed to simulate interactive conversations and deliver real-time data. It has quickly become a tool that provides instantaneous information that can be more focused than a Google search.1 We,…
Ethics Forum: The Current Landscape of Artificial Intelligence in Medicine
A handful of articles on artificial intelligence (AI) have graced the pages of this publication in the past six years, including one by Bharat Kumar, MD, in November 2022. Dr. Kumar highlighted the exciting potential of AI in rheumatology, including machine learning (ML) algorithms for the prediction of response to methotrexate and a predictive model…
Physicians vs. Artificial Intelligence
When patients have questions, can artificial intelligence (AI) generate accurate, comprehensive answers? Ye et al. conducted a single-center, cross-sectional survey of rheumatology patients and physicians in Edmonton, Canada, to explore that question.
What Changes May the Next Decade Bring to Rheumatology?
Is it 2024 already? It seems like yesterday that I stuffed all my earthly belongings into my black Volkswagen Jetta and headed from Lexington, Ky., to Iowa City, Iowa, to start my rheumatology fellowship.1 That was 10 years ago. Now, in 2024, as I go online—particularly on social media—and see the various happy, smiling faces…
Welcome to ACR Convergence!
SAN DIEGO—Award presentations & artificial intelligence topped the list in the ACR Convergence 2023 Opening Session & Keynote Lecture on Nov. 11.
The ACR Opposes New AI-Based Decision-Making Platform
On July 1, Blue Cross Blue Shield of North Carolina introduced a machine-learning technology platform to make decisions about patients’ care and treatment. The ACR opposes its use on grounds that it may harm patients’ access to treatment and undermine the doctor-patient relationship.